The Human Gut Microbiome: The Trillion Organisms That Govern More Than Just Your Digestion
Your gut contains roughly 38 trillion microorganisms that influence your mood, weight, immune system, and possibly your personality. Here is what science actually knows.
Admin
Author
You are never alone
Consider this: you are, in some meaningful sense, more microbial than human. The human body contains roughly 30 trillion human cells, but it harbours approximately 38 trillion microbial cells — bacteria, archaea, fungi, and viruses — most of them concentrated in a single extraordinary ecosystem in your large intestine. This community, collectively known as the gut microbiome, has co-evolved with humans for hundreds of thousands of years. It is not a parasite or a by-product of living in a dirty world. It is, increasingly, understood to be a functional organ — one that digests food we cannot otherwise process, trains our immune system, communicates with our brain, and influences everything from our weight to our emotional state.
The science of the microbiome is young, fast-moving, and sometimes overhyped. It has attracted headlines claiming the gut bacteria explain obesity, depression, autism, Alzheimer's, and asthma. Some of these links are supported by solid evidence. Others are promising hypotheses. Learning to distinguish them requires understanding what the microbiome actually does.
Staggering numbers, staggering diversity
The 38 trillion microorganisms in your gut belong to thousands of distinct species. A healthy human gut typically hosts between 500 and 1,000 different bacterial species, though estimates vary. Their collective genetic material — the microbiome — contains approximately 150 times more genes than the human genome itself. These microbial genes encode enzymes and metabolic pathways that human cells simply do not have.
The most important function of these genes is fermenting dietary fibre. Human cells cannot break down complex plant carbohydrates called polysaccharides. Gut bacteria can — producing short-chain fatty acids (SCFAs) in the process, particularly butyrate, propionate, and acetate. Butyrate is the primary energy source for the colonocytes (cells lining the colon) and has potent anti-inflammatory effects. Without gut bacteria, humans would absorb significantly fewer calories from plant foods and lack key metabolites that regulate immune function.
The composition of your microbiome is shaped by genetics, birth mode, early childhood diet and antibiotic exposure, geography, and ongoing diet throughout life. It is simultaneously highly individual — no two people have identical microbiomes — and remarkably consistent within an individual over time.
The gut-brain axis: your second brain
The gut and brain are in constant, bidirectional communication via what researchers call the gut-brain axis. This network involves the vagus nerve (a massive nerve running from the brainstem through the chest to the abdomen), the enteric nervous system (a semi-autonomous nervous system embedded in the gut wall containing around 500 million neurons), and a remarkable array of chemical messengers including hormones, neuropeptides, and neurotransmitters.
The most striking fact about this axis is the direction of its major signals. Approximately 90% of the fibres in the vagus nerve carry signals from the gut to the brain, not the other way round. The gut is, in a very real sense, talking to your brain almost continuously.
And what it talks in is, partly, serotonin. Roughly 90% of the body's serotonin — the neurotransmitter associated with mood regulation and often targeted by antidepressant drugs — is produced not in the brain but in the gut, primarily by enterochromaffin cells in the intestinal lining. Gut bacteria influence the activity of these cells and the production of serotonin, which then signals the brain via the vagus nerve.
This does not mean taking a probiotic will cure depression — the picture is considerably more complicated. But it does mean the idea that mood is purely a brain phenomenon is increasingly untenable. Studies in germ-free mice (raised in sterile conditions with no gut bacteria) show profoundly abnormal anxiety and stress-response behaviour compared to normal mice — behaviour that can be partially normalised by transplanting gut bacteria from normal mice.
Obesity and the Firmicutes/Bacteroidetes ratio
One of the most discussed findings in microbiome research emerged from studies comparing the gut bacteria of obese and lean individuals. Two dominant bacterial phyla — Firmicutes and Bacteroidetes — appear in different proportions in obese versus lean people. Specifically, obese individuals tend to have a higher ratio of Firmicutes to Bacteroidetes compared to lean individuals. When obese people lost weight, their Firmicutes/Bacteroidetes ratio shifted toward that of lean people.
The explanation may lie in energy harvest. Firmicutes are particularly efficient at extracting calories from dietary fibre — essentially extracting more energy from the same food. This would mean that two people eating identical diets could absorb different numbers of calories based on their microbiome composition.
This research, led by Jeffrey Gordon at Washington University in landmark studies published from 2006 onwards, was reinforced by mouse experiments in which transplanting the gut bacteria from obese mice into germ-free lean mice caused the lean mice to become obese — despite no change in diet. The causal role of gut bacteria in obesity appears real, though it is one factor among many, not a complete explanation.
What antibiotics do to your microbiome
Antibiotics are among the most life-saving interventions in medical history, but they are ecologically indiscriminate. They do not target pathogens selectively — they kill bacteria broadly, including the beneficial species in your gut.
A single course of antibiotics can reduce gut microbial diversity by 25–50%. For most people, diversity largely recovers over weeks to months — but "largely" is doing significant work in that sentence. Studies using detailed sequencing have shown that some species, once wiped out, do not return for months, and in some cases do not fully recover even after two years. The more courses of antibiotics a person has received — particularly in early childhood, when the microbiome is still developing — the more depleted their long-term diversity.
This matters because microbial diversity is consistently associated with better health outcomes across multiple disease categories. Lower diversity microbiomes are associated with inflammatory bowel disease, obesity, type 2 diabetes, and allergic conditions. Whether the low diversity causes these conditions or is a consequence of them (or both) is an active area of research.
How you are first colonised: the birth microbiome
The womb is largely sterile. At birth, a baby's gut is effectively empty of bacteria — and the first colonisation event is therefore enormously consequential for lifelong microbiome development.
During vaginal birth, the baby passes through the birth canal and is exposed to the mother's vaginal and faecal microbiota. The dominant bacteria in vaginal delivery are Lactobacillus species, which rapidly colonise the newborn gut and provide early protection against pathogens.
Caesarean section babies, by contrast, are not exposed to this microbial passage. Their initial colonisation comes from skin bacteria and the hospital environment — a very different starting community. Multiple large studies have shown that C-section babies have lower microbiome diversity in infancy and higher rates of conditions including asthma, allergies, and obesity in childhood and adulthood. The effect size is modest, and many other factors — breastfeeding, diet, antibiotic exposure — shape the microbiome powerfully in the months and years after birth. But the birth route appears to create a lasting and partially non-recoverable difference in microbiome composition.
Some hospitals now trial "vaginal seeding" for C-section babies — swabbing the newborn with gauze pre-placed in the mother's vagina. The practice is controversial and not yet standard, as the evidence base is still developing and there are theoretical infection risks.
The evidence on probiotics: nuanced, not revolutionary
Probiotics — live bacterial cultures consumed in food or supplement form — are a billion-dollar industry. The marketing often implies they will repopulate and optimise your gut microbiome. The actual evidence is more modest.
For healthy adults with a normal microbiome, most clinical trials show that probiotic supplements do not significantly colonise the gut or persistently shift the microbiome composition. The bacteria pass through and are mostly expelled. The gut microbiome is remarkably resistant to invasion by outsiders — a feature that protects it from pathogens but also limits the impact of supplemental bacteria.
Where probiotics do show clear, reproducible benefit is in specific clinical contexts. They are effective at reducing the risk of antibiotic-associated diarrhoea. Certain strains (Lactobacillus rhamnosus GG, Saccharomyces boulardii) reduce the duration and severity of acute gastroenteritis. In premature infants, probiotics reduce the risk of necrotising enterocolitis, a life-threatening gut condition.
For general wellbeing claims — improved mood, energy, immunity — the evidence is weak to non-existent in healthy populations. The microbiome is too complex and individual for a one-strain supplement to reliably improve it.
What diet does, and the diversity principle
If supplements disappoint, diet empowers. The strongest consistent finding across microbiome research is that dietary diversity — eating a wide variety of plant foods — is the single most reliable way to support a diverse, healthy microbiome.
The American Gut Project, a citizen science initiative analysing the microbiomes of thousands of volunteers, found that people who ate more than 30 different plant species per week had dramatically more diverse microbiomes than those who ate 10 or fewer — regardless of whether they ate meat, followed a vegan diet, or took probiotics. The fibre in plants feeds different microbial species; variety feeds variety.
Fermented foods — yoghurt, kefir, kimchi, sauerkraut — show genuine promise. A 2021 Stanford study in Cell found that a high-fermented-food diet increased microbial diversity and reduced inflammatory markers more effectively than a high-fibre diet alone.
The fecal transplant revolution
The most dramatic intervention in microbiome medicine is also the most stomach-turning: fecal microbiota transplantation (FMT). The procedure involves transferring stool from a healthy donor — now increasingly delivered as capsules or colonoscopically — into the gut of a recipient, with the goal of repopulating a depleted or dysbiotic microbiome.
FMT is extraordinarily effective for one specific indication: recurrent Clostridioides difficile (C. diff) infection, a bacterial infection that causes severe colitis and is notoriously difficult to treat with antibiotics. In clinical trials, FMT achieves cure rates of 80–90% in recurrent C. diff — vastly superior to antibiotic therapy. It is now a recognised standard of care.
Trials are underway for inflammatory bowel disease, obesity, autism, Parkinson's disease, and multiple sclerosis, with mixed but intriguing early results. The field is moving fast.
The bottom line
The gut microbiome is a genuine organ — one that we largely ignored for most of medical history. Its influence extends from digestion to immunity, from body weight to mental health, from birth to old age. The science is advancing rapidly, and claims often outrun evidence. What is solidly established: diversity matters, diet shapes it profoundly, antibiotics damage it (sometimes persistently), early colonisation has lifelong effects, and the gut-brain connection is real and bidirectional. The practical upshot is less exotic than a probiotic industry would like: eat more plants, more variety, more fermented foods, and treat antibiotics as the powerful and ecologically consequential drugs they are.